1. Market Research
  2. > Transportation
  3. > Air Transport Market Trends
Asia Pacific Healthcare Contract Research Organizations Services Market to 2027 - Service Type ; Therapeutic Indication ; End User (Medical Device Companies, Pharmaceutical and Biopharmaceutical Companies, Others, and Country

Asia Pacific Healthcare Contract Research Organizations Services Market to 2027 - Service Type ; Therapeutic Indication ; End User (Medical Device Companies, Pharmaceutical and Biopharmaceutical Companies, Others, and Country

  • August 2020
  • 153 pages
  • ID: 5953739
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Oct 31st 2020

Summary

Table of Contents

Search Inside

The Asia Pacific healthcare contract research organizations (CRO) services market is expected to reach US$ 16,745.94 million by 2027 from US$ 7,559.03 million in 2019. The market is estimated to grow at a CAGR of 10.6% during 2020–2027. The growth of the healthcare contract research organizations (CRO) services market is primarily attributed to the growing number of clinical trials as well as increasing expenditure in R&D and outsourcing activities in the Asia Pacific region. Factors such as dearth of skilled professional hamper the growth of the market. Additionally, rising biosimilars and biologics market and advancement of technology in research field are likely to fuel the growth of the healthcare contract research organizations (CRO) services market during the forecast period.
Contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product.Pharmaceutical & biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bio analytical testing services, and regulatory services.

CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies, required to conduct the extensive range of testing services to comply with the national and international regulatory standards.
Biotherapeutics is the fastest-growing segment in the pharmaceutical industry.The efficacy and safety of biotherapeutics associated with the ability to treat various untreatable diseases is majorly driving the growth of the biosimilars and biologics.

Technological advancement and significant improvement in the understanding of diseases such as cancer and rheumatoid arthritis are creating a demand for the development of biosimilars and biologics.Pharmaceutical and biopharmaceutical companies are investing heavily in the R&D activities to develop innovative and advanced biological molecules.

Companies are capitalizing on their expertise in biologics manufacturing to generate more revenue by fulfilling the unmet conditions. In recent years, there has been an increase in the biologics license application (BLA).
The Asia Pacific regions are important locations for the development of biosimilars.Biologics are large complex molecules, up to 1,000 times the size of small molecule generic drugs.

To save the in-house cost and time required for these testing services throughout the development process of the biologics and biosimilars in the initial stages, the companies prefer to outsource these services to the pre-clinical CROs. This is expected to be a potential opportunity for the growth of the pre-clinical CROs in the coming years.
Asia Pacific countries are estimated to witness massive challenges due to increasing COVID-19.Prohibitory measures have been taken to control the spread of this pandemic.

However, in this measure, hospitals, clinics, diagnostic centers, and ambulatory surgery centers (ASCs) are not taking general patient on priority.Apart from the overall health system, healthcare contract research organizations (CRO) services have been facing challenges due to COVID-19 outbreak.

Thus, such cancellation of studies is likely to negatively affect the growth of the market.
Based on service type, the healthcare contract research organizations (CRO) services market is segmented into early phase development, laboratory services, consulting services, and clinical research services.The early phase development segment is further categorized into discovery studies, chemistry, marketing & manufacturing, and preclinical market.

The laboratory services segment is further sub segmented as bio-analytical testing and analytical testing.The clinical research services segment is further divided into phase I, phase II, phase III, and phase IV.

In 2019, the clinical research segment accounted for the largest share of the market. Growth of this segment is attributed to the increasing clinical trials and growing R&D investment.
The World Health Organization (WHO), the International Society for Pharmaceutical Engineering, the China Food and Drug Administration (CFDA), National Cancer Registry Programme of the India Council of Medical Research (ICMR), and India Brand Equity Foundation (IBEF) are among the significant secondary sources associated with the Asia Pacific healthcare contract research organizations (CRO) services market report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($3000)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Europe Ground Handling Software Market to 2027- COVID-19 Impact and Analysis by Airport Class, Application, Software Type, and Country

  • $ 3000
  • August 2020
  • 86 pages

The Europe ground handling software market was valued at US$ 812.60 million in 2019 and is projected to reach US$ 1235.30 million by 2027; it is expected to grow at a CAGR of 5.68% from 2020 to 2027. The ...

  • Europe
  • Ground Handling
  • Industry analysis
  • Aircraft Fleet Size
  • Software Revenue

ref:plp2020

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on